大前庭水管综合征患者ABR和人工耳蜗术后EABR反应特征分析北大核心CSCD

目的探讨大前庭水管综合征(LVAS)患者的听性脑干反应(ABR)及人工耳蜗植入术后电诱发听性脑干反应(EABR)的特点,为LVAS患者人工耳蜗植入围手术期的电生理监测反应特征提供参考。方法选择2013年1月至2016年3月在我院行人工耳蜗植入的14例大前庭水管综合征患者。记录人工耳蜗植入前ABR反应阈值及潜伏期,观察声诱发短潜伏期负反应(ASNR)的表现,并统计该波的出现概率。记录患者术后EABR波形、V波阈值及III、V波潜伏期,计算III、V波引出率及EABR分级。比较ABR的V波和EABR的V波的潜伏期差异。比较ABR出现与不出现ASNR组的EABR反应阈值和V波潜伏期差异。结果 14例患者中有5例术前ABR可引出ASNR,9例无ASNR,V波潜伏期6.6～8.15ms。人工耳蜗植入后有13例引出有意义的EABR波形,平均EABR阈值为190.8CL,平均III波潜伏期为1.80ms,平均V波潜伏期为3.59ms,有1例EABR未引出反应。根据Gibson EABR分级标准,ASNR组与无ASNR组EABR波形分化无明显差异。ASNR组EABR阈值177.5CL,无AS-NR组阈值196.7CL,二者有统计学差异。ASNR组V波潜伏期4.71ms,无ASNR组V波潜伏期4.68ms,二者无统计学差异。EABR的V波潜伏期比ABR的V波潜伏期短,二者有统计学差异。结论 LVAS患者的ABR反应中出现ASNR波是其听力学特征性表现之一,但EABR记录不到相应的短潜伏期负反应。EABR的V波潜伏期较ABR短。植入前存在ASNR的大前庭水管综合征患者具有较低的植入后EABR反应阈。     

人工耳蜗植入术后NRT与EABR动态变化研究

目的观察人工耳蜗植入后短期神经反应遥测（neural response telemetry,NRT）、电诱发听性脑干反应（electrically auditory brainstem response EABR）的动态变化,探讨人工耳蜗植入术后神经传导通路的动态变化。方法：对12例极重度感音神经性聋患者分别于人工耳蜗植入术后1月（开机）及术后2月（开机1月）行NRT、EABR检测,观察NRT、EABR阈值及EABR波v潜伏期变化。结果：术后1月及术后2月NRT阈值无显著性差异（P〉0．05）;术后2月与术后1月相比,20号电极EABR阈值显著降低（P〈0．05）、EABR波V潜伏期显著缩短（P〈0．05）。10号、3号电极在两个不同时间点EABR阈值、EABR波V潜伏期均无显著性差异（P〈0．05）.结论：人工耳蜗植入术后短期内,NRT阈值变化不明显,而EABR阈值、波V潜伏期在发生变化,提示人工耳蜗术后患者的听觉神经传导通路具有动态变化趋势。     

人工耳蜗植入术中EABR监测的应用

目的探讨人工耳蜗植入术中进行EABR监测的方法，以了解耳蜗电刺激下听觉传导通路的神经反应情况。方法20例人工耳蜗植入患者，男14例，女6例，平均年龄13．6岁，语前聋患者14例，语后聋患者6例。全麻后安置体表记录电极，将PPS与听觉诱发电位仪触发端口连接，并选定听觉诱发电位仪的外触发模式。人工耳蜗电极植入后，先行常规NRT监测，然后将NRT刺激参数改为EABR模式，采用Basic双极刺激，脉宽50μs，强度由200CL起以10CL为步长递减至反应阈值。结果20例患者均记录到EABR，阈上20CL时Ⅲ波．Ⅴ波的平均潜伏期分别为2．04±0．20ms．3．96±0．41ms。相同刺激条件下的EABR反应平均阈值为148．46±11．63CL，NRT反应平均阈值为160．72±13．56CL。一例脑白质轻度发育异常患儿，术中NRT波形引出良好，EABRⅠ～Ⅳ波分化良好，Ⅴ波波形低钝，Ⅴ波／Ⅲ波振幅比〈1／2，考虑可能存在耳蜗核上性神经发育不良，现正在语言康复训练随访中。结论人工耳蜗植入术中进行EABR监测比NRT能提供更完整的．更接近听觉中枢的神经反应信息，能更进一步了解听觉传导通路的功能状态，以期对患者听力康复的效果提供更准确的预测。     

人工耳蜗植入者电听性脑干反应测试

目的　通过对人工耳蜗植入者的电听性脑干反应 (electricallyevokedauditorybrainstemresponses,EABR)检测 ,探讨术后患者的电听觉传导通路的功能状态和EABR阈值。方法　对 6例人工耳蜗植入患者术后进行EABR检测。分别选取近耳蜗底转、中部和近蜗顶部三个固定部位的蜗内电极作为刺激电极 ,进行EABR记录 ,将所测EABR阈值与主观阈值和NRT(neuralresponsetelemetry)阈值进行比较。结果　 6例患者 ,用 175电流级 (currentlevel)的刺激强度 ,每一部位都可记录到清晰易识别、重复性良好的EABR波形 ,在耳蜗底转 ,中部和蜗顶部电极测得EABR波Ⅲ平均潜伏期分别为 1.83± 0 .19、1.80± 0 .18、1.6 8± 0 .2 3ms ,波Ⅴ平均潜伏期分别为 3.90± 0 .16、3.74±0 .18、3.6 2± 0 .2 4ms;测得EABR平均阈值分别为 16 5 .33± 7.6 6、16 2 .6 7± 7.2 8、15 3.33± 8.0 2电流级。结论　EABR是了解人工耳蜗植入者听觉传导功能的存在及测定人工耳蜗植入术后听觉阈值的客观方法之一     

人工耳蜗植入术中电刺激中潜伏期听觉诱发电位的检测

目的 建立人工耳蜗植入术中电刺激中潜伏期听觉诱发电位(electrical evoked middle latency response,EMLR)的检测方法,为进一步评估植入者听觉传导通路及高位听觉反应的特点奠定基础.方法 20例人工耳蜗植入者,其中语前聋14例,语后聋6例,全部使用Cochlear公司Nucleus CI24R (CA)人工耳蜗.术中将言语处理器与计算机接口及听觉诱发电位仪触发端口连接,电极植入后,选取第3号电极,先常规进行电刺激听神经复合动作电位(electrically evoked auditory nerve compound active potentials,ECAP)测试初步了解听神经功能状态,然后进行EMLR检测.选择电刺激听性脑干反应(electrical auditory brainstem response,EABR)模式,采用单极刺激,双相交替脉冲电流方波,脉宽50 ～ 100μs,强度(电流级,current leve1,CL)由ECAP阈值上20 CL起,以5 CL为步长递减或递增,听觉诱发电位仪记录EMLR波形.对ECAP阈值与EMLR阈值进行相关性分析.另外选择6名听力正常健康受试者,行声刺激中潜伏期听觉诱发电位(auditory middle latency response,AMLR)测试,作为EMLR波形和潜伏期的声刺激对照.结果 6例听力正常受试者均可记录到AMLR波形,平均反应阈为(12.5±8.6)dBnHL,接近纯音测听阈值(10.8 ±7.3)dBHL.20例人工耳蜗植入者均可记录到EMLR波形,与AMLR波形相似,但各波潜伏期和波间期缩短,波幅变化不大;语前聋较语后聋总体上波幅小,潜伏期长.EMLR平均阈值为(140.55 ±9.92)CL,低于ECAP的平均阈值 ( 160.75±13.34) CL,差异具有统计学意义(t=10.467,P＜0.01);二者阈值之间呈正相关(r=0.763,P＜0.01).结论 人工耳蜗植入术中可成功记录到EMLR波形,其阈值较ECAP低,可以作为判断植入者中枢高位听觉传导功能的客观检查.     

电诱发听性脑干反应的电生理特征及其在人工耳蜗植入中的评估价值

目的:探讨电诱发听性脑干反应(EABR)的电生理特征及对残余听神经数量的评估作用。方法:用Bio-logic Navigator Pro诱发电位仪记录,通过Cochlear Nucleus 24CA植入体给予刺激,对23例人工耳蜗使用者进行术后EABR测试,并与行为学测试及神经反应遥测技术(NRT)结果相比较。结果:23例患儿均记录到EABR的Ⅲ～Ⅴ波,其波形特点及起源与ABR相似。EABR的阈值为(172.61±14.61)CL,阈上20CL时Ⅲ、Ⅴ波的潜伏期分别为(2.93±0.18)ms、(4.80±0.28)ms,较ABR相应缩短1～2ms,而Ⅲ-Ⅴ波间期不变,为(1.86±0.18)ms。EABR阈值与行为学结果、NRT阈值均有相关性,EABR的输入-输出函数曲线斜率与术后电刺激行为学动态范围有相关性(P<0.05)。结论:EABR能够客观反映听觉传导通路的功能状态,为预测残余的听神经数量提供了一定的参考价值。     

电诱发听性脑干反应在人工耳蜗植入术后的临床应用分析[论著]

目的　探讨电诱发听性脑干反应（electrically evoked auditory brainstem responses，EABR）的特性和其在判断人工耳蜗植入术后听觉传导通路完整性中的作用，以及不同脉冲宽度的EABR阈值与人工耳蜗植入术后调试行为测试数值之间的相关性，为人工耳蜗植入术后首次开机不会配合行为测试的植入者科学设定刺激参数提供参考。方法　选取郑州市第三人民医院植入诺尔康晨星人工耳蜗（CS-10A植入体）、能配合行为测试的植入者20例，采用行为测试测得阈值（T值）和最大舒适阈（C值），在标准屏蔽室内做ABR检查，采用3、10、20电极分别测脉冲宽度为25、50、75 μs/相的EABR平均阈值，分析引出率和波形分化特点，并对两种数据进行统计学分析。结果　EABR越容易引出波形越清晰，患儿的听觉反应越灵敏，也反映了术后植入体系听觉传导通路越完整（P<0.05）；EABR脉冲宽度为75 μs/相的平均阈值与人工耳蜗的C值有良好的相关性（P<0.05）。结论　EABR检测可客观的判断人工耳蜗植入术后植入体系完整的听觉传导功能，客观评价人工耳蜗植入效果。人工耳蜗调试中，可以通过EABR脉冲宽度为75 μs/相的平均阈值来指导不能配合主观行为测试的植入者C值的判定，为患儿早期开始听觉刺激，建立听觉重塑带来帮助。     

语前聋听神经病多道人工耳蜗植入效果初步观察

目的 探讨听神经病患者人工耳蜗植入后的电生理结果 变化并分析其听力言语康复效果.方法 对行人工耳蜗植入术的2例听神经病患儿进行术前听力学评估,术中、术后听觉诱发电位反应监测及开机后1年的随访,获得其开机后6个月与12个月时的听力言语康复效果,并与人工耳蜗使用时间相近的非听神经病耳蜗植入患儿的康复效果进行对比.结果 例1术中神经反应遥测henral response telemetry,NRT)及电刺激听性脑干诱发反应(electric auditory brainstem response,EABR)可引出波形,但重复性不好,EABR V波潜伏期延长.开机12个月时复查,2项电生理检查均引出可重复波形,EABR V波潜伏期在正常范围;听力言语康复效果显著提高,开机1年后有意义听觉整合量表得分优于对照组儿童;例2术中NRT未引出有意义波形,EABR可引出波形,但重复性不好;开机12个月复查,2项电生理检查均引出可重复波形,EABR V波潜伏期在正常范围;术后听力言语康复效果亦有所提高.结论 2例听神经病患者人工耳蜗植入后,术前听觉通路电活动的去同步化均得到一定程度的恢复,听力言语能力也有不同程度提高,说明人工耳蜗植入可以作为听神经病患者实现听力重建,重返主流社会的治疗和康复手段.     

ECAP检出与否的人工耳蜗植入患者的EABR表现

目的比较分析ECAP检出与否的耳蜗植入患者EABR特点,探讨EABR检测的意义。方法对26例人工耳蜗植入患者分别行神经反应遥测neural response telemetry,NRT）检测评估ECAP,并进行电诱发听洼脑干反应（electrically auditory evoked response,EABR）检测,将第20、10、3号电极均引出ECAP波形的14例患者纳入A组,未检出ECAP波形的12例患者纳入B组。对A、B两组患者的EABR阈值、V波潜伏期进行比较分析。结果A、B两组患者20、10、3号电极EABR阈值之间的差异有统计学意义（P〈0．001）,V波潜伏期之间的差异无统计学意义（P〉0．05）。结论ECAP波形引出与否人工耳蜗植入患者的EABR阈值有显著差异,v波潜伏期无明显差异。     

不同脉宽条件下人工耳蜗植入者术中 电诱发听性脑干反应检测的特点分析

摘要：目的比较不同脉宽条件下人工耳蜗植入者术中电诱发听性脑干反应（electrically evoked auditory brainstem response,EABR）的特点,分析脉宽与EABR波V引出率和阈值之间的关系,总结不同脉宽条件对EABR波V引出率和阈值的影响,选择更优化的EABR脉宽测试参数。方法无残余听力的人工耳蜗植入患者24例作为实验组,其中耳蜗形态正常12例、大前庭导水管综合征（large vestibular aqueduct syndrome,LVAS）4例、Mondini畸形4例、共同腔畸形（common cavity deformation,CCD）2例、内听道狭窄2例;筛选条件相近的24例有残余听力的人工耳蜗植入者配对作为对照组。应用改装的Cochlear Freedom人工耳蜗及自制的铂铱合金球电极对拟行人工耳蜗植入的两组者术中分别给予50、100、200 μs不同脉宽的电刺激,Bio logic Navigator Pro听觉诱发电位仪记录不同脉宽条件下EABR波V引出率和阈值。结果脉宽50、100、200 μs时,EABR波V引出率实验组（均为91.7%）低于对照组（分别为100%、100%、95.8%）,差异无统计学意义（P均>0.05）;而EABR阈值实验组［分别为(183.73±8.96)CL、(151.28±10.05)CL、(120.56±12.82)CL］高于对照组［分别为(175.50±9.14)CL、(142.71±11.45)CL、(110.63±10.24)CL］,差异均具有统计学意义(t值分别为18.87、16.82、17.64,P均<0.05)。结论蜗内单极刺激能诱发出良好的EABR波形,无残余听力的患者EABR阈值要明显高于有残余听力的患者。相对于脉宽200 μs,50、100 μs时EABR波形波V引出率高;脉宽50 μs波形分化更好、动态范围广,内耳畸形严重可能需要适当加大刺激量（如将脉宽改为100 μs）。     

The expression of vascular endothelial growth factor (VEGF) and VEGF‐C in early laryngeal cancer: relationship with radioresistance

The expression of vascular endothelial growth factor (VEGF) and VEGF‐C in early laryngeal cancer: relationship with radioresistance Angiogenesis is essential for tumour growth and invasion. Vascular endothelial growth factor (VEGF) is a prime mediator of tumour angiogenesis. VEGF‐C is a closely related protein that effects lymphatic endothelial cells and may be important in the process of lymphatic metastasis. The purpose of this study was to evaluate the expression of these cytokines in patients with T1 and T2a glottic, squamous cell carcinoma, in comparison with normal epithelial control tissue, to ascertain any association with radioresistance. Twenty‐two tumours treated by radiotherapy (13 radiosensitive, nine radioresistant) and seven normal control tissues were studied. The minimum follow‐up was 2 years after radiotherapy. Expression of VEGF and VEGF‐C was evaluated by immunohistochemistry of formalin‐fixed, paraffin‐embedded biopsy specimens. Analysis was carried out using a quantitative computer image analyser. Both VEGF and VEGF‐C were detectable in tumour and normal control specimens. There was increased expression in tumour specimens of both VEGF (P = 0.03) and VEGF‐C (P < 0.001). In addition, the expression of VEGF‐C was associated with tumours of higher histological grade (P = 0.021). There was, however, no difference in VEGF and VEGF‐C expression between radioresistant and radiosensitive tumours. The expression of VEGF and VEGF‐C is increased in early laryngeal squamous cell carcinoma (SCC). However, measuring the expression of these proteins cannot predict radioresistance in this tumour group.     

Treatment of Maxillary Sinus Carcinoma: Clinical Results Using the Kitasato Modality

The conventional therapeutic regimen for maxillary sinus carcinoma consists of dissection of the maxilla, full-dose irradiation and extensive chemotherapy. However, the results obtained with this treatment are often poor. Even when patients recover, their quality of life is significantly reduced as a result of deformity of facial structures and swallowing and articulation dysfunctions. A retrospective analysis of 68 patients with maxillary sinus carcinoma treated with the Kitasato modality between 1975 and 1999 was conducted. All patients underwent pergingival maxillary sinus surgery combined with pre- and postoperative irradiation therapy with standardized total doses of 16 Gy; the postoperative irradiation was given in combination with regional intra-arterial infusion chemotherapy administered via the superficial temporal artery. All visible tumor lesions were removed where possible in order to preserve or facilitate cellular immunity after surgery. The cumulative 5-year survival rates were 85.7% for Stage II patients, 88.1% for Stage III, 76.6% for Stage IVA and 75.0% for Stage IVB.     

Tongue Base Reduction with Temperature-controlled Radiofrequency Volumetric Tissue Reduction for Treatment of Obstructive Sleep Apnea Syndrome

In recent years a considerable effort has been made to establish the use of different surgical techniques for the treatment of obstructive sleep apnea syndrome (OSAS). Nevertheless, treatment of hypopharyngeal obstruction due to tongue base hypertrophy remains in many ways an unsolved problem. The aim of this study was to evaluate the safety and efficacy of tongue base reduction with temperature-controlled radiofrequency volumetric tissue reduction in the treatment of OSAS. Twenty patients with OSAS and tongue base hypertrophy were treated with radiofrequency tissue ablation. An intensified treatment protocol was used, delivering 2,800 J per treatment session under local anesthesia. Two nights of polysomnography testing were performed before and after treatment. Daytime sleepiness, snoring and postoperative morbidity were assessed using questionnaires. Mean respiratory disturbance index (RDI) was reduced from 32.1 to 24.9/h after a mean of 3.4 treatment sessions. Six patients (33%) were cured after the procedure (reduction in RDI of &#83 50% and a postoperative RDI of <15/h) and ten (55%) showed an improvement of >20% in their RDI. Daytime sleepiness and snoring improved significantly. Peri- and postoperative morbidity was low; one severe complication occurred (tongue base abscess). We were able to achieve similar cure and responder rates to those reported in a recently published pilot study but with a reduced number of treatment sessions. We believe that this technique may improve patient acceptance and have beneficial cost implications.     

Cervical Reflex Induced by Click Stimuli in Cats

We studied click-evoked potentials in the anterior horn of the spinal cord in 17 cats. A concentric needle electrode was inserted into the anterior horn of the spinal cord at levels C3-C6. Potentials evoked with 105 dB SPL clicks were recorded with a peak latency of 4.89-5.10 ms only at the C3 level. These responses were observed 45-60 dB SPL above the auditory brainstem response (ABR) threshold, and no potentials were evoked by stimulation of the contralateral ear. Average was performed 100 times with changes in stimulation frequency of 1-20 Hz. The amplitude of the potentials decreased with increasing stimulus frequency, but there were no changes in ABRs. The responses disappeared after destruction of the medial vestibulospinal tract at the obex level, but ABRs were still recorded. The spinal nucleus of the accessory nerves was located in the anterior horn of the spinal cord at levels C1-C6, and the sternocleidomastoid muscle motoneurons were found at levels C1-C3. The click-evoked potentials recorded in this study reflect responses of the spinal nucleus of accessory nerves through the vestibulospinal tract to click stimulation. The responses have the same characteristics as vestibular-evoked myogenic potentials that can be recorded using surface electrodes over the sternocleidomastoid muscles of humans.     

Lack of significant estrogen and progesterone receptor expression in nasal telangiectasias in hereditary hemorrhagic telangiectasia: an immunohistochemical analysis

Obstructive sleep apnea syndrome (OSAS) is characterized by snoring and apnea during sleep leading to decreased oxygen saturation and disturbed sleep, excessive daytime sleepiness and neuropsychological disturbances. This study investigates cognitive neuropsychological abilities in a group of 53 OSAS patients before and after treatment with uvulopalatopharyngoplasty. General intellectual ability, verbal learning and memory as well as executive functioning were measured at baseline and 6 months postoperatively. After surgery there were significant improvements in verbal learning and memory (mean change - 39, SD 57.3, p <0.001), recall (mean change - 24.3, SD 39.3, p <0.001) and executive functioning (as assessed by percentage of errors on the Wisconsin Card Sorting Test; mean change-9.1, SD 15.7, p <0.001). These improvements were in accordance with improvements in the degree of sleep apnea, the oxygen desaturation index (mean change -9.7, SD 15.9, p <0.001) and arterial minimum oxygen saturation (mean change 4.5%, SD 10.2%, p <0.01). Surgical treatment seems to improve verbal learning, memory and recall and executive functions in parallel with better oxygenation in OSAS.     

Measurement of chemosensory function

Although hundreds of thousands of patients seek medical help annually for disorders of taste and smell, relatively few medical practitioners quantitatively test their patients' chemosensory function, taking their complaints at face value. This is clearly not the approach paid to patients complaining of visual, hearing, or balance problems. Accurate chemosensory testing is essential to establish the nature, degree, and veracity of a patient's complaint, as well as to aid in counseling and in monitoring the effectiveness of treatment strategies and decisions. In many cases, patients perseverate on chemosensory loss that objective assessment demonstrates has resolved. In other cases, patients are malingering. Olfactory testing is critical for not only establishing the validity and degree of the chemosensory dysfunction, but for helping patients place their dysfunction into perspective relative to the function of their peer group. It is well established, for example, that olfactory dysfunction is the rule, rather than the exception, in members of the older population. Moreover, it is now apparent that such dysfunction can be an early sign of neurodegenerative diseases such as Alzheimer's and Parkinson's. Importantly, older anosmics are three times more likely to die over the course of an ensuring five-year period than their normosmic peers, a situation that may be averted in some cases by appropriate nutritional and safety counseling. This review provides the clinician, as well as the academic and industrial researcher, with an overview of the available means for accurately assessing smell and taste function, including up-to-date information and normative data for advances in this field.